Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04815018 · ClinicalTrials.gov registry record
Shifts in the Respiratory Microbiome and Clinical Outcomes of SARS-CoV-2
A clinical trial, sponsored by Pathnostics.
- Terminated
- Registry status
- 185
- Enrollment target
NCT04815018 is a clinical trial that was terminated before completion, run by Pathnostics. The registered enrollment target is 185 participants.
The verdict
NCT04815018 was terminated before completion, sponsored by Pathnostics.
- TERMINATED
- Registry status
- 185 participants
- Enrollment target
Study Summary
This is a longitudinal, prospective observational study focusing on health-related outcomes relative to potential changes in the respiratory microbiome seen with weekly SARS-CoV-2 testing in nursing home residents.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2020-10-07 |
| Est. Completion | 2021-05-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04815018
The ClinicalTrials.gov registry entry for NCT04815018 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 185 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pathnostics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04815018 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04815018 about?
NCT04815018 is a clinical study titled "Shifts in the Respiratory Microbiome and Clinical Outcomes of SARS-CoV-2". This is a longitudinal, prospective observational study focusing on health-related outcomes relative to potential changes in the respiratory microbiome seen with weekly SARS-CoV-2 testing in nursing home residents.
What is the current status of trial NCT04815018?
This trial is currently terminated. The enrollment target is 185 participants. The study started on 2020-10-07. Estimated completion is 2021-05-30.
Who is sponsoring clinical trial NCT04815018?
This trial is sponsored by Pathnostics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.